Myles Wolf's Insider Trades & SAST Disclosures

Myles Wolf's most recent trade in Akebia Therapeutics Inc. was a trade of 53,600 Stock Option (Right to buy) done . Disclosure was reported to the exchange on June 10, 2025.

Share

Note

This is a custom search result for pattern Myles Wolf.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Akebia Therapeutics Inc.	Myles Wolf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2025	53,600	53,600	-		-	Stock Option (Right to buy)
Akebia Therapeutics Inc.	Myles Wolf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2025	35,700	133,381 (0%)	0%		0	Common Stock
Akebia Therapeutics Inc.	Myles Wolf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	45,000	45,000	-		-	Stock Option (Right to buy)
Akebia Therapeutics Inc.	Myles Wolf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2024	30,000	97,681 (0%)	0%		0	Common Stock
Akebia Therapeutics Inc.	Myles Wolf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2023	45,000	45,000	-		-	Stock Option (Right to buy)
Akebia Therapeutics Inc.	Myles Wolf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2023	30,000	67,681 (0%)	0%		0	Common Stock
Akebia Therapeutics Inc.	Myles Wolf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2022	20,100	20,100	-		-	Stock Option (Right to buy)
Akebia Therapeutics Inc.	Myles Wolf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2022	13,700	37,681 (0%)	0%		0	Common Stock
Akebia Therapeutics Inc.	Myles Wolf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2021	20,100	20,100	-		-	Stock Option (Right to buy)
Akebia Therapeutics Inc.	Myles Wolf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2021	13,700	23,981 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades